Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
15336-1 Antibiotic XXX Titr Isolate+Ser Pt SemiQn SBT &nbsp; ACTIVE Other Antibiotic [Susceptibility] by Serum bactericidal titer &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; titer &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 15336-1 &nbsp; SBT &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Other Antibiotic Titr SBT &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Islt; Isol; Other Antibiotic; Point in time; Random; Schlichter test; Sequence based typing; Serum; SERUM BACTERICIDAL TITER; Serum killing test; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {titer} &nbsp; &nbsp; &nbsp; 0
15337-9 Antibiotic XXX^peak Titr Isolate+Ser Pt SemiQn SBT &nbsp; ACTIVE Other Antibiotic [Susceptibility] by Serum bactericidal titer --peak &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; titer &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 15337-9 &nbsp; SBT &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Other Antibiotic Peak Titr SBT &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Islt; Isol; Other Antibiotic; Point in time; Post; Postdose; Post-dose; Random; Schlichter test; Sequence based typing; Serum; SERUM BACTERICIDAL TITER; Serum killing test; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {titer} &nbsp; &nbsp; &nbsp; 0
15338-7 Antibiotic XXX^trough Titr Isolate+Ser Pt SemiQn SBT &nbsp; ACTIVE Other Antibiotic [Susceptibility] by Serum bactericidal titer --trough &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; titer &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 15338-7 &nbsp; SBT &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Other Antibiotic Trough Titr SBT &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Islt; Isol; Other Antibiotic; Point in time; Pre; Predose; Pre-dose; Random; Schlichter test; Sequence based typing; Serum; SERUM BACTERICIDAL TITER; Serum killing test; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {titer} &nbsp; &nbsp; &nbsp; 0
15339-5 Trogoderma angustum Ab.IgE ACnc Ser Pt Qn &nbsp; &nbsp; ACTIVE Berlin Beetle IgE Ab [Units/volume] in Serum &nbsp; MIN DefinitionDescription &nbsp; &nbsp; kIU/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ALLERGY &nbsp; 15339-5 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Berlin Beetle IgE Qn &nbsp; &nbsp; &nbsp; Y &nbsp; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Berlin beetle; i76; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR 2.42 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; k[IU]/L &nbsp; &nbsp; &nbsp; 0
1534-7 Glucose^3M post 0.5 g/kg glucose IV MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Glucose [Mass/volume] in Serum or Plasma --3 minutes post 0.5 g/kg glucose IV &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1534-7 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Glucose 3M p .5 g/kg Glc IV SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 3M p .5 g/kg Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; 0
15340-3 Cedar italian Ab.IgE ACnc Ser Pt Qn &nbsp; &nbsp; ACTIVE Italian Cedar IgE Ab [Units/volume] in Serum &nbsp; MIN DefinitionDescription &nbsp; &nbsp; kIU/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ALLERGY &nbsp; 15340-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Italian Cedar IgE Qn &nbsp; &nbsp; &nbsp; Y &nbsp; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Italian Cedar; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR 2.42 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; k[IU]/L &nbsp; &nbsp; &nbsp; 0
15341-1 Simulium venustum Ab.IgE ACnc Ser Pt Qn &nbsp; &nbsp; ACTIVE Black Fly IgE Ab [Units/volume] in Serum &nbsp; MIN DefinitionDescription &nbsp; &nbsp; kIU/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ALLERGY &nbsp; 15341-1 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Black Fly IgE Qn &nbsp; &nbsp; &nbsp; Y &nbsp; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Black fly; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; k[IU]/L &nbsp; &nbsp; &nbsp; 0
15342-9 Vespa crabro Ab.IgE ACnc Ser Pt Qn &nbsp; &nbsp; ACTIVE European Hornet IgE Ab [Units/volume] in Serum &nbsp; MIN DefinitionDescription &nbsp; &nbsp; kIU/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ALLERGY &nbsp; 15342-9 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 European Hornet IgE Qn &nbsp; &nbsp; &nbsp; Y &nbsp; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; European hornet; i75; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; k[IU]/L &nbsp; &nbsp; &nbsp; 0
15343-7 Blood group antibody Titr Ser/Plas Pt SemiQn Blood group antibody screen &nbsp; ACTIVE Blood group antibody screen [Titer] in Serum or Plasma &nbsp; NAM DefinitionDescription &nbsp; &nbsp; titer &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 15343-7 &nbsp; Blood group antibody screen &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Bld gp Ab Scn Titr SerPl &nbsp; &nbsp; &nbsp; Y &nbsp; Ab; Bld gp Ab Scn; BLOOD BANK; Dilution factor; Dilution Factor (Titer); Pl; Plasma; Plsm; Point in time; Random; Scn; Scr; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr 2.79 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {titer} &nbsp; &nbsp; Release 2.79: COMPONENT: Triggered by Coll w SCT: Screen should be omitted from Component. It should be in Method.; 0
15344-5 little i Ab Titr Ser/Plas Pt SemiQn &nbsp; &nbsp; ACTIVE little i Ab [Titer] in Serum or Plasma &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; titer &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 15344-5 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 little i Ab Titr SerPl &nbsp; &nbsp; &nbsp; Y &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); i; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {titer} &nbsp; &nbsp; &nbsp; 0
15345-2 Aldosterone^1H post XXX challenge MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Aldosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge &nbsp; MIN DefinitionDescription &nbsp; &nbsp; ng/dL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 15345-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Aldost 1h p chal SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ng/dL &nbsp; &nbsp; &nbsp; 0
15346-0 Aldosterone^30M post XXX challenge MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Aldosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge &nbsp; MIN DefinitionDescription &nbsp; &nbsp; ng/dL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 15346-0 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Aldost 30M p chal SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 30M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.7 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ng/dL &nbsp; &nbsp; &nbsp; 0
15347-8 Somatotropin^30M post XXX challenge MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge &nbsp; MIN DefinitionDescription &nbsp; &nbsp; ug/L;ng/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 15347-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 GH 30M p chal SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 30M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ng/mL &nbsp; &nbsp; Changed Order_Obs from 'Observation Only' to 'Both' to fit current order use cases. 0
15348-6 Alkaline phosphatase.liver 1/Alkaline phosphatase.total CFr Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Alkaline phosphatase.liver 1/Alkaline phosphatase.total in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15348-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 ALP Liver 1 CFr SerPl &nbsp; &nbsp; &nbsp; Y &nbsp; Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; ALP Liver; ALP Liver 1; ALP-1; AP; Catalytic Fraction; Chemistry; Hepatology; i; Liver; Percent; Phos; Phosphtase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
15349-4 Alkaline phosphatase.liver 2/Alkaline phosphatase.total CFr Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Alkaline phosphatase.liver 2/Alkaline phosphatase.total in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15349-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 ALP Liver 2 CFr SerPl &nbsp; &nbsp; &nbsp; Y &nbsp; Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; ALP Liver; ALP Liver 2; ALP-1; AP; Catalytic Fraction; Chemistry; Hepatology; II; Liver; Percent; Phos; Phosphtase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
1535-4 Glucose^40M post 0.5 g/kg glucose IV MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Glucose [Mass/volume] in Serum or Plasma --40 minutes post 0.5 g/kg glucose IV &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1535-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Glucose 40M p .5 g/kg Glc IV SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 40M p .5 g/kg Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.34 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; 0
15350-2 Amylase CRat Urine 2H Qn &nbsp; &nbsp; ACTIVE Amylase [Enzymatic activity/time] in 2 hour Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; U/2 H &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15350-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Amylase 2h Ur-cRate &nbsp; &nbsp; &nbsp; Y &nbsp; 120 min; 120 minutes; 120min; 2 hours; 2HR; Alpha amylase; Ams; Amyl; Catalytic Rate; Chemistry; cRate; Diastase; Gastro; Gastroenterology; GI; k87; QNT; Quan; Quant; Quantitative; UA; UR; Urn 2.7 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; U/(2.h) &nbsp; &nbsp; &nbsp; 0
15351-0 Apolipoprotein E2 PrThr Bld Pt Ord &nbsp; &nbsp; ACTIVE Apolipoprotein E2 [Presence] in Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15351-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Apo E2 Bld Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; APO; Apo E2; Apolipo; Apolipoprot; Apolipoprotein E-II; Apolipoproteins; Blood; Chemistry; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Preferred nomenclature uses Arabic numbers for Apolipoprotein E (NCBI/OMIM). Changed E-II to E2.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
15352-8 Apolipoprotein E3 PrThr Bld Pt Ord &nbsp; &nbsp; ACTIVE Apolipoprotein E3 [Presence] in Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15352-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Apo E3 Bld Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; APO; Apo E3; Apolipo; Apolipoprot; Apolipoprotein E-III; Apolipoproteins; Blood; Chemistry; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Preferred nomenclature uses Arabic numbers for Apolipoprotein E (NCBI/OMIM). Changed E-III to E3.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
15353-6 Apolipoprotein E4 PrThr Bld Pt Ord &nbsp; &nbsp; ACTIVE Apolipoprotein E4 [Presence] in Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15353-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Apo E4 Bld Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; APO; Apo E4; Apolipo; Apolipoprot; Apolipoprotein E-IV; Apolipoproteins; Blood; Chemistry; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Preferred nomenclature uses Arabic numbers for Apolipoprotein E (NCBI/OMIM). Changed E-IV to E4.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
15354-4 Bombesin Ag PrThr Tiss Pt Ord Immune stain &nbsp; ACTIVE Bombesin Ag [Presence] in Tissue by Immune stain &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PATH &nbsp; 15354-4 &nbsp; Immune stain &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Bombesin Ag Tiss Ql ImStn &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Antigen; Antigens; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified 2.56 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
15355-1 Estrone sulfate MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Estrone sulfate [Mass/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15355-1 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Estrone Sulfate SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; E1; E1S; Gyn; Gynecology; Level; Mass concentration; OB; ObGyn; Obstetrics; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; 0
15356-9 Globulin MRat Urine 24H Qn &nbsp; &nbsp; ACTIVE Globulin [Mass/time] in 24 hour Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mg/24 H &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15356-9 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Globulin 24h Ur-mRate &nbsp; &nbsp; &nbsp; Y &nbsp; 1 day; 24 hours; 24HR; Chemistry; GLB; Glob; Glob%; Globul; Globulins; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/(24.h) &nbsp; &nbsp; &nbsp; 0
15357-7 Iron MCnt Tiss Pt Qn &nbsp; &nbsp; ACTIVE Iron [Mass/mass] in Tissue &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mcg/100mg; mcg/gm; ug/g &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15357-7 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Iron Tiss-mCnt &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Fe; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ug/g &nbsp; &nbsp; &nbsp; 0
15358-5 Macroamylase PrThr Ser/Plas Pt Ord &nbsp; &nbsp; ACTIVE Macroamylase [Presence] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 15358-5 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Macroamylase SerPl Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Chemistry; Macro amylase; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
108,248 results found